Door Opens To Gene Editing In Embryos.
This is not unexpected in the American scene, as other countries with less stringent laws have ventured forth in this critical area of experimentation given the current advancement in available gene editing technology. The recent recommendations of the National Academies of Sciences and the National Academy of Medicine facilitated this process, proposing stringent rules to govern the bases for these explorations, by limiting them to diseases that had no known antidote, where its progression is very serious, and where the genes in question had been confirmed to cause that particular disease. Oversight and accountability are always necessary, as is currently being practiced. When these tests are conducted on embryos and/or living human beings, the ethical issues predominate, and it ought to be the focus of consistent and tight regulatory management in view of garnering public trust
Read Article Here: